How to Test Human-Specific Combination Immunotherapies In Vivo
Por um escritor misterioso
Descrição
Learn how to evaluate combinations of human-specific checkpoint inhibitors in vivo, with double knock-in humanized drug target mouse models.
The difficulty in translating the preclinical success of combined TGFβ and immune checkpoint inhibition to clinical trial - eBioMedicine
Mechanism of chemoradiation-immunotherapy combination in esophageal
Advancing Precision Medicine: In Vitro Potency Assays for Evaluating the Function of anti-PD-1 Checkpoint Inhibitors
Pharmaceutics, Free Full-Text
Cell-based Immunotherapy
Biodegradable lipophilic polymeric mRNA nanoparticles for ligand-free targeting of splenic dendritic cells for cancer vaccination
Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies
A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases - eBioMedicine
Nanotechnology-based products for cancer immunotherapy
Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment
de
por adulto (o preço varia de acordo com o tamanho do grupo)
.jpg)
